Reduction in Glucose Levels in STZ Diabetic Rats by 4-(2,2-Dimethyl-1-oxopropyl)benzoic Acid: A Prodrug Approach for Targeting the Liver.

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionORIGINAL ARTICLEThis notice is a correctionReduction in Glucose Levels in STZ Diabetic Rats by 4-(2,2-Dimethyl-1-oxopropyl)benzoic Acid: A Prodrug Approach for Targeting the Liver.Gregory R. Bebernitz, Jeremy G. Dain, Rhonda O. Deems, Dario A. Otero, W. Ronald Simpson, and Robert J. StrohscheinCite this: J. Med. Chem. 2002, 45, 5, 1150Publication Date (Web):January 23, 2002Publication History Published online23 January 2002Published inissue 1 February 2002https://pubs.acs.org/doi/10.1021/jm010571hhttps://doi.org/10.1021/jm010571hcorrectionACS PublicationsCopyright © 2002 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views372Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (28 KB) Get e-Alertsclose Get e-Alerts

Related Papers

• → Design and synthesis of factor Xa inhibitors and their prodrugs(2003)26 cited
• → Orally bioavailable prodrugs of a BCS class 2 molecule, an inhibitor of HIV-1 reverse transcriptase(2008)12 cited
• → Prodrugs to Codrugs(2017)3 cited
• → Concept of Prodrug(2015)1 cited
• The progress of antitumor prodrug in target tumor therapy(2007)